Promises and pitfalls of oral cancer chemotherapy.
Ergolin
Merrill J
MJ
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001549:Benzamides; D016903:Drug Monitoring; D000068877:Imatinib Mesylate; D055118:Medication Adherence; D009369:Neoplasms / Q000188:drug therapy*; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D010879:Piperazines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate